We accelerate the journey from molecule to market by delivering end-to-end CDMO solutions. We are present in APIs, Finished Dosage (OSD), Generics, Injectables, Biologics, and CRO segments, ensuring faster, safer, and smarter access to life-changing therapies worldwide.
As a leader in pharmaceutical innovation, we serve as a trusted CDMO partner, helping global healthcare companies deliver life-saving therapies to patients more quickly, safely, and effectively.
Seamless support from preclinical research to full-scale commercialisation.
Seamless support from preclinical research to full-scale commercialisation.
Manufacturing Facilities
We operate two advanced manufacturing facilities (Unit 1 & Unit 2), approved by the USFDA and EU-GMP.
Greenfield API Facility (DCS-Controlled)
Our newest greenfield API facility (Unit-3) is equipped with an advanced Distributed Control System (DCS).
Research Capabilities
Our R&D centre in India houses over 175 highly skilled scientists. It features Synthetic Chemistry Labs, Process Engineering Labs, Analytical Labs, and a Patent Cell.
We are committed to sustainable growth by adopting responsible environmental, social, and governance (ESG) practices. We aim to make a positive impact through our main initiatives.
Our Story
Businesses
Therapies
Corporate Identification No : U24231GJ1991PLC015132
©2026 Cadila Pharmaceuticals. All rights reserved
